You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SYRE Sale Disclosure
Albers Jeffrey W. · SEC Form 4 · Filed Aug 10, 2026
Sale
Calculated transaction value
$522.35K
Albers Jeffrey W. Director
SYRE
Spyre Therapeutics
SYRE
Transaction date
Aug 7, 2026
Public filing date
Aug 10, 2026
Filing lag
Filed 3 days later
SYRE daily price context
Close on/before transaction
$104.91
Aug 7, 2026
First close after public filing
$102.74
Aug 11, 2026
30-day return after filing
-15.39%
Through Sep 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,000 shares @ $104.47
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001636282-26-000102
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$2.46M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Spyre Therapeutics, Inc. SYRE | Exercise | Aug 7, 2026 | $51.95K |
| Spyre Therapeutics, Inc. SYRE | Exercise | Aug 7, 2026 | $0 |
| Spyre Therapeutics, Inc. SYRE Current | Sale | Aug 7, 2026 | $522.35K |
| Spyre Therapeutics, Inc. SYRE | Sale | Aug 7, 2026 | $835.04K |
| Spyre Therapeutics, Inc. SYRE | Sale | Aug 7, 2026 | $1.05M |